Literature DB >> 22056365

Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature.

William M Yarbrough1, Rupak Mukherjee, Robert E Stroud, William T Rivers, J Marshall Oelsen, Jennifer A Dixon, Shaina R Eckhouse, John S Ikonomidis, Michael R Zile, Francis G Spinale.   

Abstract

OBJECTIVE: Patients with severe left ventricular pressure overload secondary to aortic stenosis can present with signs and symptoms of heart failure despite normal left ventricular ejection fraction. This process occurs, at least in part, as a result of left ventricular pressure overload-induced extracellular matrix remodeling that promulgates increased left ventricular stiffness and impaired diastolic function. However, the determinants that drive extracellular matrix remodeling in this form of left ventricular pressure overload remain to be fully defined.
METHODS: Left ventricular pressure overload was induced in mature pigs (n = 15) by progressive ascending aortic cuff inflation (once per week for 4 weeks), whereby left ventricular mass, left ventricular ejection fraction, and regional myocardial stiffness (rK(m)) were compared with referent controls (n = 12). Determinants of extracellular matrix remodeling were assessed by measuring levels of mRNA expression for fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinase 1 and 4.
RESULTS: With left ventricular pressure overload, left ventricular mass and rK(m) increased by 2- and 3-fold, respectively, compared with control, with no change in left ventricular ejection fraction. Left ventricular myocardial collagen increased approximately 2-fold, which was accompanied by reduced solubility (ie, increased cross-linking) with left ventricular pressure overload, but mRNA expression for fibrillar collagen and matrix metalloproteinases remained relatively unchanged. In contrast, a robust increase in mRNA expression for tissue inhibitors of matrix metalloproteinase-1 and 4 occurred with left ventricular pressure overload.
CONCLUSIONS: In a progressive model of left ventricular pressure overload, which recapitulates the phenotype of aortic stenosis, increased extracellular matrix accumulation and subsequently increased myocardial stiffness were not due to increased fibrillar collagen expression but rather to determinants of post-translational control that included increased collagen stability (thereby resistant to matrix metalloproteinase degradation) and increased endogenous matrix metalloproteinase inhibition. Targeting these extracellular matrix post-translational events with left ventricular pressure overload may hold both diagnostic and therapeutic relevance. Published by Mosby, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056365      PMCID: PMC3241904          DOI: 10.1016/j.jtcvs.2011.09.032

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  31 in total

1.  Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.

Authors:  S Hinan Ahmed; Leslie L Clark; Weems R Pennington; Carson S Webb; D Dirk Bonnema; Amy H Leonardi; Catherine D McClure; Francis G Spinale; Michael R Zile
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosis.

Authors:  Jordi S Dahl; Lars Videbaek; Mikael K Poulsen; Patricia A Pellikka; Karsten Veien; Lars Ib Andersen; Torben Haghfelt; Jacob E Møller
Journal:  Am J Cardiol       Date:  2010-07-23       Impact factor: 2.778

3.  Activation of apoptotic caspase cascade during the transition to pressure overload-induced heart failure.

Authors:  Narain Moorjani; Manzoor Ahmad; Pedro Catarino; Robin Brittin; Danyah Trabzuni; Futwan Al-Mohanna; Navneet Narula; Jagat Narula; Stephen Westaby
Journal:  J Am Coll Cardiol       Date:  2006-09-12       Impact factor: 24.094

4.  Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.

Authors:  F G Spinale; M L Coker; C V Thomas; J D Walker; R Mukherjee; L Hebbar
Journal:  Circ Res       Date:  1998-03-09       Impact factor: 17.367

5.  Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure.

Authors:  Rachael Deardorff; Francis G Spinale
Journal:  Biomark Med       Date:  2009-10-01       Impact factor: 2.851

Review 6.  The role of matrix metalloproteinase 7 in innate immunity.

Authors:  Bernard Burke
Journal:  Immunobiology       Date:  2004       Impact factor: 3.144

7.  Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart.

Authors:  Stephane Heymans; Blanche Schroen; Pieter Vermeersch; Hendrik Milting; Fangye Gao; Astrid Kassner; Hilde Gillijns; Paul Herijgers; Willem Flameng; Peter Carmeliet; Frans Van de Werf; Yigal M Pinto; Stefan Janssens
Journal:  Circulation       Date:  2005-08-15       Impact factor: 29.690

8.  Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats.

Authors:  Fumitaka Kuwahara; Hisashi Kai; Keisuke Tokuda; Mamiko Kai; Akira Takeshita; Kensuke Egashira; Tsutomu Imaizumi
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

9.  Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model.

Authors:  Robert F Foronjy; Jie Sun; Vincent Lemaitre; Jeanine M D'Armiento
Journal:  Hypertens Res       Date:  2008-04       Impact factor: 3.872

10.  Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement.

Authors:  H P Krayenbuehl; O M Hess; E S Monrad; J Schneider; G Mall; M Turina
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

View more
  35 in total

1.  Creation of clinically relevant model of chronic heart failure: Application of multi-modality imaging to define physiology.

Authors:  Stephanie Thorn; Albert J Sinusas
Journal:  J Nucl Cardiol       Date:  2015-02-20       Impact factor: 5.952

2.  The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.

Authors:  Lydia E Matesic; Lisa A Freeburg; Laura B Snyder; Lauren-Ashley Duncan; Amber Moore; Paige E Perreault; Kia N Zellars; Edie C Goldsmith; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-08-21       Impact factor: 4.733

Review 3.  Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase.

Authors:  Joseph S Janicki; Francis G Spinale; Scott P Levick
Journal:  Pflugers Arch       Date:  2013-02-16       Impact factor: 3.657

4.  Imaging technologies for cardiac fiber and heart failure: a review.

Authors:  Shana R Watson; James D Dormer; Baowei Fei
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

5.  Non-human primate and rat cardiac fibroblasts show similar extracellular matrix-related and cellular adhesion gene responses to substance P.

Authors:  Giselle C Meléndez; Edward J Manteufel; Heather M Dehlin; Thomas C Register; Scott P Levick
Journal:  Heart Lung Circ       Date:  2014-12-05       Impact factor: 2.975

6.  Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Fouad A Zouein; Yonggang Ma; Vincent Dive; Lisandra E de Castro Brás; Merry L Lindsey
Journal:  Int J Cardiol       Date:  2015-03-05       Impact factor: 4.164

7.  Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.

Authors:  William M Yarbrough; Catalin Baicu; Rupak Mukherjee; An Van Laer; William T Rivers; Richard A McKinney; Corey B Prescott; Robert E Stroud; Parker D Freels; Kia N Zellars; Michael R Zile; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

Review 8.  Membrane-associated matrix proteolysis and heart failure.

Authors:  Francis G Spinale; Joseph S Janicki; Michael R Zile
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

9.  Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension.

Authors:  Heather M Dehlin; Edward J Manteufel; Andrew L Monroe; Michael H Reimer; Scott P Levick
Journal:  Int J Cardiol       Date:  2013-07-29       Impact factor: 4.164

10.  Heart failure with preserved ejection fraction: chronic low-intensity interval exercise training preserves myocardial O2 balance and diastolic function.

Authors:  Kurt D Marshall; Brittany N Muller; Maike Krenz; Laurin M Hanft; Kerry S McDonald; Kevin C Dellsperger; Craig A Emter
Journal:  J Appl Physiol (1985)       Date:  2012-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.